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Abstract 
The achievement and the maintenance of asthma control is currently considered the main goal of asthma treatment. Recent 
guidelines recommend regular assessment of asthma control and indicate questionnaires as important tools that can facilitate its 
evaluation. Questionnaires relate to GINA or NAEPP guidelines. Questionnaires constitute complex numerical or categorical scales 
and consist of several to over a dozen questions relating to the patient’s symptoms of asthma, limitations in daily activities and 
usage of rescue medications within a period of time. Each questionnaire is characterized by the features that affect its reliability 
and usefulness.
In the following paper we discuss most of the questionnaires which assess asthma control. We focus on the items they include 
and present the results of studies that prove the effectiveness of individual questionnaires in assessment of asthma control. 
Attention was drawn to the patient groups to which the questionnaires are addressed. We list the features of the questionnaire 
which should be considered before choosing a test, so that it satisfies both the doctor’s and the patient’s needs.
The role of questionnaires as the easy-to-use tools is growing steadily. Unfortunately, not all are available in Polish language. 
Conducting appropriate validation studies may allow to use many of them in Polish conditions.
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Streszczenie
Aktualnie uznaje się, że nadrzędnymi celami leczenia astmy są uzyskanie i utrzymanie jej prawidłowej kontroli. Najnowsze wy-
tyczne zalecają regularną ocenę kontroli astmy i wskazują kwestionariusze jako ważne narzędzia, które mogą ułatwiać jej ocenę. 
Kwestionariusze odnoszą się do istniejących wytycznych GINA lub NAEPP. Mają charakter złożonych skal liczbowych lub katego-
rycznych i składają się z od kilku do kilkunastu pytań odnoszących się do występujących u chorego objawów astmy, ograniczeń 
w codziennej aktywności i stosowanego leczenia doraźnego w określonym czasie. Każdy kwestionariusz charakteryzuje się 
cechami, które wpływają na jego wiarygodność i przydatność.
W niniejszej pracy omówiono większość kwestionariuszy służących do oceny kontroli astmy. Wymieniono elementy wchodzące 
w ich skład, sposób pomiaru kontroli choroby oraz wyniki badań, które udowadniają skuteczność poszczególnych kwestionariuszy 
w procesie oceny kontroli astmy. Zwrócono uwagę na grupę pacjentów, do których są adresowane kwestionariusze. Wymieniono 
parametry testu, którymi należy się kierować przy jego wyborze, tak by odpowiadał on potrzebom lekarza i pacjenta.
Rola kwestionariuszy, jako łatwych w użyciu narzędzi pomagających przeprowadzić ocenę kontroli astmy, systematycznie rośnie. 
Niestety, nie wszystkie są dostępne w języku polskim. Przeprowadzenie odpowiednich badań walidacyjnych może umożliwić 
zastosowanie wielu z nich w warunkach polskich.
Słowa kluczowe: astma, kontrola astmy, test kontroli astmy, kwestionariusz kontroli astmy
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Introduction
Asthma is a chronic inflammatory disease 
of the airways, in which the enormous progress 
of treatment has been recently achieved. The in-
troduction of new drugs gave a chance to obtain 
complete control of symptoms in many patients. 
However, asthma remains an incurable disease, 
and in some patients symptoms still persist and 
severe, life-threatening exacerbations occur despite 
optimal treatment. Therefore, the goal of asthma 
treatment is to achieve and maintain proper control 
of the disease, to minimize the risk of exacerbations 
and to prevent further disease progression [1].
Asthma control is defined as the extent to 
which symptoms of the disease have been re-
duced by treatment. The term of asthma control 
is multidimensional and includes daytime and 
night symptoms, daily life activity, lung function, 
and use of medications. In the last decade the 
emphasis has been put not only on the severity of 
symptoms, but also on the risk of adverse events 
in the future. Those adverse events are exacer-
bations, impaired lung function and side effects 
of treatment [2].
GINA guidelines show how to assess asthma 
control and future risk of the disease in a simple 
way, just by asking a few questions about asthma 
symptoms and by lung function measurement [1]. 
As shown by observational real-life studies, 
a substantial proportion of patients, reaching even 
higher than 50%, can not achieve satisfactory 
control of the disease [3−10]. In recent times, in 
addition to the GINA guidelines, several ques-
tionnaires are available that allow in a quick and 
affordable way to assess asthma control without 
the need for costly, complex and sometimes dif-
ficult to access additional tests.
GINA guidelines
The need to establish the concept of asthma 
control was noticed in the late 90’s of the last 
century. The term first appeared in the GINA 
guidelines published in 2006 [11]. The guidelines 
recommended basing treatment decisions on the 
level of asthma control rather than on its severity. 
The goal of treatment was to achieve and maintain 
full control of the disease [11]. For this reason, the 
guidelines advice how to carry out an assessment 
of asthma control. It is based on three questions, 
which concern the frequency of symptoms of the 
disease, use of short-acting inhaled bronchodi-
lators and spirometry (percentage of predicted 
values of PEF or FEV1). Rated symptoms are the 
daily symptoms, the limitation of daily activity 
and nocturnal symptoms or awakenings caused 
by asthma. Spirometric assessment includes PEF 
or FEV1 measurement and estimation whether the 
measured value is higher or lower than 80% of 
predicted value. The time period undergoing mea-
surement is four weeks prior to the assessment. 
Depending on the results, asthma is defined as to-
tally controlled, partly controlled or uncontrolled.
After 2006, GINA guidelines has been sig-
nificantly modified. The most important change 
is the introduction of the concept of the future 
adverse outcomes risk in form of exacerbations, 
fixed airflow limitation and medication side 
effects. The changes were implemented follow-
ing the guidelines of the US National Asthma 
Education and Prevention Program Expert Panel 
Report 3 (NAEPP EPR3) published in 2007 [12]. 
This is a very significant modification, because 
finding specific risk factors significantly increases 
the likelihood of exacerbations in the future. In 
addition, the guidelines point out risk factors 
for fixed airflow limitation and medication side 
effects. They are listed in Table 1.
Table 1.  Risk factors for poor asthma outcomes in the 
future according to GINA 2014 [1]
Tabela 1. Czynniki ryzyka niekorzystnych wydarzeń  
w przyszłości, według GINA 2014 [1]
Potentially modifiable risk independent factors for flare-ups 
(exacerbations)
Uncontrolled astma symptoms
Excessive short-acting beta agonist (SABA) use
Inadequate inhaled corticosteroid (ICS): not prescribed,  
poor adherence, incorrect inhaler technique
Low FEV1, especially if < 60% predicted
Major psychological or socioeconomic problems
Exposures: smoking, alergen exposure if sensitized
Comorbidities: obesity, rhinosinusitis, confirmed ford allergy
Pregnancy
Sputum or blood eosinophilia
1 severe exacerbation in last 12 months 
Ever intubated or In intensiva care unit for asthma
At least one severe exacerbation In last 12 months
Risk factors for developing fixe airflow limitation
Lack of ICS treatment
Low initial FEV1
Chronic mucus hypersecretion
Sputum or blood eosinophilia
Exposures: tobacco smoke, noxious chemicals, occupational 
exposures
Risk factors for medication side-effects:
Systemic: frequent oral corticosteroid, long term, high dose and/or  
potent ICS, also taking P450 inhibitors
Local: high dose or potent ICS, poor inhaler technique
Pneumonologia i Alergologia Polska 2015, vol. 83, no. 3, pages 220–228 
222 www.pneumonologia.viamedica.pl
Table 2. Asthma symptom control according to GINA 2014 [1]
Tabela 2. Kontrola objawów astmy, według GINA 2014 [1]
Asthma symptom control Level of asthma symptom control
In the past 4 weeks has the patent had: 
(answer yes/no):
Daytime asthma symptoms more  
than twice/week?
Any night waking due to asthma?
Reliever needed for symptoms more than 
twice/week?
Any activity limitation due to asthma?
Well controlled Partly controlled Uncontrolled
Answers „yes” for none  
of these questions
Answers „yes” for 1−2  
of these questions
Answers „yes” for 3−4  
of these questions
It is worth noting that from 2014, the spiro-
metric assessment of lung function is no longer 
a basis for assessing the control of the disease [1]. 
Asthma control is evaluated only by questions 
about asthma symptoms and use of rescue med-
ications. FEV1 is an element used to identify 
patients at risk of asthma exacerbations. The 
new guidelines also extend the period of time 
undergoing assessment, from one to four weeks. 
The latest assessment criteria of asthma control 
according to GINA 2014 are presented in Table 2.
Rules for the assessment of asthma control 
proposed in the GINA guidelines are applicable for 
adults, adolescents and children over 11 years of 
age [1]. For children aged 6−11 years, in addition 
to questions about symptoms control (identical to 
those in adults), an additional set of questions for 
parents was prepared. These questions concern 
the child’s behavior in everyday life, intolerance 
of physical exertion, increased fatigue, irritability, 
the severity of viral respiratory infections and oth-
er symptoms resulting from the lack of adequate 
control of the disease. A separate questionnaire 
was also prepared for parents of children under 
6 years of age.
Presence of daytime asthma symptoms for 
more than a few minutes, more than once a week, 
activity limitation during play or exercise, night 
waking and coughing due to asthma and the need 
for reliever medication more often than once 
a week mean partial control or lack of control of 
the disease in the child. Assessment of the risk 
of adverse events in the future is based on other 
grounds than in adults because performance of 
spirometry is impossible. Moreover, some specific 
problems exist in this age group, which include 
respiratory viral infections, the typical flare-up 
period (usually autumn and fall), psychological 
and social problems of the child or the family, 
poor adherence to medication and incorrect in-
halation technique [1].
NAEPP EPR3 Guidelines
In 2007, in the United States, National 
Asthma Education and Prevention Program Ex-
pert Panel Report 3 (NAEPP EPR3) guidelines 
were published. The guidelines for the first 
time highlighted the role of disease control 
in asthma management [12]. According to the 
recommendations, assessment of asthma control 
results from rating of two domains: impairment 
imposed by the disease and future risk of ad-
verse events.
Assessment of impairment domain is based 
upon questions about daily and night asthma 
symptoms, limitation of daily activities, rescue 
use of bronchodilators and evaluation of lung 
function (FEV1 or PEF). Moreover, results of 
validated asthma control questionnaires are 
taken into account. Guidelines mention ACT 
(Asthma Control Test), ACQ (Asthma Control 
Questionnaire) and ATAQ (Asthma Therapy 
Assessment Questionnaire). They will be dis-
cussed below. After assessment of the mentioned 
above parameters the patient is assigned to one 
of three groups: well controlled, poorly con-
trolled and uncontrolled asthma. Time period 
under assessment is two to four weeks preceding 
examination.
The second domain which is assessed, is 
future risk. It is evaluated by determining the 
number of exacerbations requiring systemic 
corticosteroids during the last year. Patients 
who have had at least two such flare-ups have 
reduced global rate of disease control, even if 
the assessment of impairment domain was con-
sistent with well-controlled asthma. In addition, 
side effects of the treatment are evaluated. The 
guidelines also provide specific recommenda-
tions concerning assessment of asthma control 
in children under 5 and from 5 to 11 years of 
age [12].
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Asthma Control Test (ACT)
The test is a tool for evaluating asthma con-
trol consisting of 5 questions. For each question 
patient chooses one from five possible answers. To 
each answer a point value from 1 to 5 is assigned. 
The test result is the sum of points obtained from 
the answers to all the questions. The maximum 
score (25 points) means total control of asthma, 
the result of 20 to 24 points means a partial 
control, while the result of 19 points and below 
indicates the insufficient level of disease control. 
Questions relate to a time period of four weeks 
preceding the survey. The first four questions of 
the questionnaire relate to the symptoms of the 
disease. They concern limitation of daily activity, 
dyspnea, nocturnal symptoms and the utilization 
of rescue medications. The fifth question refers 
to the patient’s self-assessment of the degree of 
asthma control in the past four weeks. The patient 
determines the degree of control as complete 
(5 points), good (4 points), moderate (3 points), poor 
(2 points), or states that in the recent four weeks 
the disease has not been controlled (1 point). ACT 
was developed in 2004 in the United States by 
a team of professionals, who have created a ques-
tionnaire consisting of 22 questions concerning 
symptoms of asthma, the impact of the disease on 
the patient’s life, use of medications, exacerba-
tions and psychosocial aspects of the disease [13]. 
Then, using the questionnaire, a large group of 
patients was studied. The same patients were then 
evaluated by specialists in terms of meeting the 
goals of asthma treatment according to current 
guidelines of the National Heart, Lung and Blood 
Institute (NHLBI). Using statistical methods, 
5 out of 22 questions were selected, according 
to which the assessment of asthma control most 
closely matched the assessment performed by 
the specialists. Furthermore, after analysis of the 
sensitivity and specificity of the questionnaire, 
the cut-off point for uncontrolled asthma was set 
at the level of 19 points. It was also found that 
the correlation between rating of disease control 
performed by ACT and by asthma specialist is 
strong, while the correlation between the result 
of the ACT and FEV1 was weak. It confirms the 
limited value of spirometry as a single tool for 
assessment of control of the disease [13].
In 2009, another study was conducted, which 
showed that the minimally important difference 
(MID) between the results of the ACT assessed at 
a different time is 3 points [14]. This means, that 
if the current patient’s score is lower by at least 
3 points in comparison to the result obtained on 
the previous visit, the clinician should consider 
changes in the treatment of the patient [14].
The test was developed for patients of 12 
years of age and older. For children between 4 and 
11 years a special version of the questionnaire 
was prepared (Childhood Asthma Control Test 
— CACT). In this version the first four questions 
are answered by a child, then the parent answers 
to additional three questions. Questions relate to 
the child’s symptoms, except one which concerns 
self-assessment of asthma control done by the 
child. In addition, the possible answers contain 
graphic elements to help the child provide the 
right answer. Questions for parents relate to the 
number of days in which they noticed daytime 
symptoms of asthma, the number of days in which 
they heard the child wheezing and the number of 
nights, during which the child woke up because of 
asthma symptoms. Cut-off point for uncontrolled 
asthma is also 19 points. 
ACT, due to the simplicity and ease of use, is 
one of the best known and most widely used tools 
for the clinical assessment of asthma control.
Asthma Control Questionnaire (ACQ)
ACQ is another questionnaire developed for 
a quick and easy assessment of asthma control. It 
was developed in 1999 by Elizabeth Juniper and 
colleagues from McMaster University in Cana-
da. The authors prepared a long list of asthma 
symptoms and sent it to independent centers in 
18 countries, with a request for specialists to de-
termine the suitability of individual symptoms in 
the evaluation of the disease control [15]. Finally, 
five symptoms were chosen, that according to 
specialists, have the greatest importance in the 
evaluation of asthma control. These are noctur-
nal awakenings due to asthma, the limitation of 
daily activity, the severity of morning symptoms 
of asthma, shortness of breath and wheezing. 
The questionnaire contains one question for 
each of these symptoms. Moreover, the authors 
added questions relating to use of short-acting 
b2-agonist and to FEV1. Thus, the test consists of 
7 questions, hence its full name ACQ7. For each 
question the patient selects one of the answers 
which are assigned numerical values from 0 to 6 
(0 means no symptoms, while 6 — their highest 
intensity). Likewise, the percentages of FEV1 are 
grouped (0 means FEV1 greater than 95% of pre-
dicted value, 6 — below 60%). All questions relate 
to the period of one week before the examination. 
The final result of the test is the mean value of 
the results obtained from individual questions 
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and from spirometry assessment. The authors 
conducted a nine-week observational study in 
patients which showed high sensitivity of ACQ to 
changes in asthma control compared with other 
methods of assessing the disease, ie. patient’s 
diary, spirometry, questionnaire of quality of life 
in asthma (Asthma Quality of Life Questionnaire 
— AQLQ) and generic test of the state of health 
(Medical Outcomes Survey Short Form 36, SF-36) 
[15]. A generic test SF-36 is a popular tool used in 
the evaluation of the quality of life in a variety of 
diseases, not only in asthma. Its usefulness in as-
sessing the quality of life in asthma was previous-
ly demonstrated [16]. Another finding from the 
study was minimally important difference (MID) 
which is 0.5 point for ACQ [17]. Interestingly, the 
cut-off point defining the lack of asthma control 
was not established. It was defined in a separate 
study in 2006. It concluded that the score of 1.5 
point and below suggests uncontrolled asthma, 
and the result of more than 1.5 point — controlled 
asthma. However, these values have not yet been 
validated and there are still doubts about the 
interpretation of the results in the range of 0.75 
— 1.5 points [18].
An important element of ACQ7 is spirom-
etry. This can cause a problem for clinicians, 
as it requires access to spirometry, prolongs the 
test taking and requires the patient to withhold 
bronchodilators before the visit. Therefore also 
a simplified versions of the test were developed: 
consisting of five (questions relating only to 
symptoms), six (questions about the symptoms 
and use of b2-agonist) and seven (the assessment 
of PEF instead of FEV1) questions. They have been 
validated and are also characterized by a good, but 
slightly lower than the full version of the ques-
tionnaire, ability to assess asthma control [17].
Asthma Therapy Assessment Questionnaire 
(ATAQ)
Another simple tool to assess asthma control 
is ATAQ. This questionnaire consists only of four 
questions, and for each question, patient chooses 
one of the two possible answers. The first ques-
tion concerns the limitation of daily activities 
and absence from work or school due to asthma, 
the second refers to the night symptoms, the 
third — to the use of rapid-acting b2-agonist more 
than 12 breaths in one day. The fourth question 
concerns the sense of good asthma control by 
the patient himself. The test period is four weeks 
prior to the visit. If the answers to the questions 
are affirmative, the patient receives one point for 
each answer, and if the answer is negative, patient 
receives zero points. Thus, patients who received 
a total score of zero has well controlled asthma, 
one or two points indicate partly controlled dis-
ease, three or four points — uncontrolled asthma. 
There is also a version of the test for children 
and adolescents aged 5 to 17 years. It consists of 
20 questions addressed to the parent. A large num-
ber of questions hinders some of its application 
in an outpatient setting, but studies have shown 
that it is a valuable tool and should be used [19].
The test was developed in 1999 in the United 
States. A large study on more than 5000 adult 
patients has shown a good correlation between 
the questionnaire and Asthma Quality of Life 
Questionnaire (AQLQ), Saint George Question-
naire and a generic questionnaire SF-36 [20]. In 
addition, the test results were higher in patients 
who reported acute health care utilization in the 
past year. It indicates the ability of the test to 
identify patients with a high risk of exacerbations 
in the future.
ATAQ is a convenient and simple tool to 
assess asthma control. Unfortunately there is no 
Polish version of the questionnaire.
Asthma Control and Communication Instrument 
(ACCI)
It is a questionnaire created in 2008 in the 
United States in response to the difficulties in 
achieving asthma control among racially diverse 
patient populations. Epidemiological studies 
have indicated a significantly worse treatment 
outcomes, more frequent exacerbations and 
a lower level of asthma control among black pa-
tients. Different reasons of this state are indicated, 
among them poor clinician-patient communi-
cation resulting from low health literacy, lower 
educational status, lack of patient self-efficacy, 
and other cultural and language barriers. In 
order to improve the quality of asthma control 
assessment among minority patients, specialists 
developed a questionnaire dedicated for them. 
It contains 12 items relating to four domains of 
the disease. These domains are Risk (exacerba-
tions or hospitalizations and the need for sys-
temic glucocorticoid since the last visit), Bother 
(about being bothered by asthma), Direction (the 
well-being and overall course of the disease since 
the last visit) and Control (intensity of asthma 
symptoms over the last week). One question con-
cerns adherence to prescribed medications. The 
patient selects one of several possible answers 
by putting an “X” in the appropriate box. Boxes 
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are filled with the color, in order to facilitate 
patient choice of the appropriate answer (green 
— with responses that indicate low intensity of 
symptoms and red — with responses indicating 
their significant severity). The questions are 
written in simple language. Next to the question 
text there are additional explanations, which are 
meant to facilitate understanding of some of the 
expressions. The last question is open, which 
means that the patient may report any problem 
with asthma, which was not included in the 
previous questions. The test result is obtained by 
calculating the mean of the sum of responses to 
each question. The questionnaire was validated 
in ethnically and economically diverse popula-
tions. The authors carried out a study that showed 
a good correlation between the assessment of 
asthma control using ACCI with the assessment 
made by other questionnaires (including ACT, 
ACQ) [21]. Unfortunately there is no version of 
the test for patients under 18 years of age. Polish 
version of the questionnaire does not exist.
30 Second Asthma Test
This is a short questionnaire developed in 
Canada in 2007. It is based on the Canadian 
Asthma Guidelines. It consists of five questions 
referring to night symptoms, daytime symptoms, 
use of short-acting bronchodilators, limitation of 
physical activity and absence from school or work 
because of asthma. For each question the patient 
indicates whether the symptom occurs (one point) 
or not (zero points). A score of two points or more 
means poor asthma control. The test refers to the 
period of the last week — in the case of asthma 
and three months — in the case of absence from 
work or school and activity limitation [22].
The test advantages which are emphasized 
are simplicity, quick and good correspondence 
with specialist rating of asthma control. Worth 
noting is the big emphasis that the authors put to 
the reduction of the patient’s activity, both phys-
ical and professional. Still, studies are needed to 
compare the accuracy of the assessment of disease 
control using this test with other questionnaires. 
There is no Polish version of the test.
Royal College of Physicians 3 Questions Asthma 
Tool (RCP3Q)
This a short questionnaire developed in the 
United Kingdom, designed to quickly identify 
patients with poorly controlled asthma, who 
require medical consultation in order to prevent 
exacerbations. It consists of three questions. 
First refers to the presence of daytime symptoms, 
second — to the presence of nocturnal symp-
toms, third — to limitation of daily activities. 
The assessment relates to the last month. For 
an affirmative answer to any of these questions 
the patient gets one point. The range of results 
is therefore between zero and three points. Zero 
points means good asthma control. Occurrence 
of daily symptoms only (and thus the result of 
a single point) may be in good control, but may 
suggest poorer disease control. Interestingly, the 
result of a single point due to the presence of 
night symptoms or limitation of daily activities 
is considered as a signal of poor asthma control 
and requires a deeper evaluation. It is the only 
questionnaire that assigns different weights to 
individual symptoms — decreased activity and 
nocturnal symptoms are regarded as more seri-
ous than daytime symptoms. The result of two 
or three points means poor asthma control. The 
questionnaire was validated during a multicenter 
study in the UK and showed a good correlation 
with the results of ACQ [23]. It is noteworthy 
that this test is a tool, which does not provide 
multidimensional assessment of asthma control, 
but it easily and quickly identifies patients who 
need urgent medical attention. There is no Polish 
version of the test.
Test for Respiratory and Asthma Control in Kids 
(TRACK)
Assessment of asthma control is particular-
ly difficult in preschool children and there are 
very few tools for such assessment. In this light, 
TRACK is an especially valuable questionnaire, 
as it is designed for children under 5 years of age. 
It was created in 2009. From a set of 33 questions 
suggested by the experts regarding different 
aspects of asthma control, five questions were 
selected, that corresponded well with the current 
NAEPP guidelines. Parent indicates how often in 
the past four weeks a child had daytime symptoms 
in form of coughing, wheezing or shortness of 
breath. Parent is also asked about the frequency 
of night awakenings due to asthma and limitation 
of the child’s activity. Another question concerns 
the use of rescue medication used to reduce the 
symptoms of the disease in the last three months 
and the last section concentrates on the frequency 
of the use of systemic corticosteroids in the past 
year. In each question parent selects one of five 
answers, which are assigned numerical values 
from 0 to 20, with 0 corresponding to the biggest 
Pneumonologia i Alergologia Polska 2015, vol. 83, no. 3, pages 220–228 
226 www.pneumonologia.viamedica.pl
severity of symptoms, and 20 — to lack of them. 
The sum of points obtained from all answers de-
termines the result of the test. The study assessing 
the usefulness of the questionnaire showed that 
children who obtained a score less than 80 points 
are at high risk of uncontrolled asthma [24]. 
Another study demonstrated its high sensitivity 
in detecting changes in asthma control during 
the period of 4−6 weeks [25]. It is worth noting 
that the questionnaire is designed not only for 
children with asthma, but also for children with 
symptoms of respiratory diseases resembling 
asthma. In the youngest children diagnosis of 
asthma is particularly difficult and the use of 
objective tests, such as spirometry is impossible. 
In contrast to TRACK, childhood ACT is dedi-
cated only for children with diagnosed asthma 
from 4 years of age. Therefore, TRACK is useful 
in the youngest patients, especially those whose 
diagnosis of asthma is not definitively confirmed, 
but the symptoms raise the suspicion of asthma. 
Polish version of this test was not prepared.
Summary
Modern guidelines encourage to the use of 
questionnaires as tools facilitating the assess-
ment of asthma control. It must be realized that 
they may have a different structure and some 
limitations.
Asthma control evaluation can be based on 
a single parameter, for example the number of 
days in month with good control of asthma or on 
FEV1. Currently, this method is not recommended. 
It was demonstrated that the correlation between 
single aspect of the disease and the degree of over-
all asthma control is low [26]. Recent guidelines 
recommend the use of composite scores, which 
evaluate several areas of the disease [1, 12].
Questionnaires can measure categorical vari-
ables by assigning responses to specific groups 
(such as the presence or absence of cough, exer-
cise tolerance or intolerance). An example of such 
tool is GINA classification of asthma control. By 
asking questions relating to specific aspects of the 
disease it assigns patients to one of three defined 
groups (asthma well controlled, partly controlled 
and uncontrolled).
Another type of questionnaires measure the 
numeric (continuous) variables. The result of the 
test is a number which is within the specified 
range, determining the degree of asthma control. 
Examples of such questionnaires are ACT and 
ACQ. The guidelines of American Thoracic Soci-
ety and European Respiratory Society published 
in 2009, recommend the use of composite tools 
measuring numeric variables, which have advan-
tage over the tools based on categorical variables 
[26, 27]. Expression of the result in a numeric 
form is simpler both for the physician and for the 
patient and facilitates observation of changes in 
asthma control over time [26, 27].
Each composite score is characterized by 
a set of certain features. They should be taken 
into consideration while choosing the right test 
for the patient. These features are listed below:
1.  Measured parameters. As discussed above, 
most of the questions in the questionnaires 
concern similar aspects of asthma control. 
A basis for assessment is constituted by the 
questions about daytime symptoms, noctur-
nal symptoms, limitation of daily activities 
and use of short acting b2-agonist. It is worth 
noting if the tool evaluates not only the cu-
rrent degree of asthma control, but also the 
future risk of exacerbations (GINA, NAEPP 
EPR3, TRACK). Prior to the selection of the 
test, clinician should also consider whether 
the need to perform spirometry will not be 
a significant obstacle to the completion, as 
it is with the full version of the ACQ. Some 
tests include questions about self-assessment 
of the control of the disease. In case of cho-
osing such a questionnaire, physician must 
be sure that a patient actually understands 
the concept of asthma control.
2. The range of values and the cut-off points for 
each degree of asthma control. The questionna-
ires consist of a different number of questions, 
which affects their complexity and the time 
needed to complete them. The simplest test 
consisting of three questions is RCP3Q, which 
is by far the easiest and fastest to solve, but in 
turn, does not include many of the issues of 
asthma control, such as the use of rescue me-
dication. ACQ is a test of greater complexity, 
which also includes the lung function para-
meter (FEV1), but this in turn may hinder its 
conduction in primary care. It should also be 
checked whether the test has clearly defined 
rules for the interpretation of the results and if 
its reliability has been confirmed by scientific 
research. For example, the ACT has clearly 
defined cut-off points for each degree of asthma 
control, whereas in the case of ACQ, as men-
tioned earlier, there are still doubts about the 
interpretation of the results in a certain range.
3. Time period undergoing assessment. The 
aforementioned tests evaluate asthma control 
over one week to one month period. It should 
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be kept in mind that different asthma symp-
toms may disappear or appear in a shorter or 
longer period of time. The GOAL study noted 
for example that the nocturnal symptoms 
disappear first after optimizing treatment, 
whereas daily symptoms severity is reduced 
after a longer time [28].
4. Repeatability. An important feature of the 
questionnaire is the repeatability of the 
measurement after a long period of time, in 
stable conditions. ACQ questionnaire was 
studied in this regard and showed good 
reproducibility in a stable period within 
1, 5 and 9 weeks after the first measurement 
[15]. This is an important feature of incre-
asing the credibility of the questionnaire.
5. Responsiveness to changes of the degree 
of asthma control. In case of the two afo-
rementioned tools, ie. ACT and ACQ, an 
attempt was made to accurately determine 
the minimally important difference in test 
result, which may involve a substantial de-
terioration of control and increased risk of 
exacerbation in the future. For ACT this value 
is 3 points [14], and for ACQ it is 0.5 point 
[17]. As for the other described tools such 
value was not established, but for some te-
sts (CACT, RCP3Q) studies confirmed their 
ability to detect response to treatment [27].
6. Validity. It is the term describing the ability 
of the test to actually measure the values 
that was designed to measure. Without 
proper validation of the test, the clinician 
can not be sure that the obtained test result 
reflects asthma control. Most questionnaires 
discussed above were validated according to 
GINA or NAEPP guidelines, or to another, 
previously validated tool designed to assess 
asthma control, or to some other parameter 
than asthma control, like the quality of life, 
the number of exacerbations or lung func-
tion. It is important to choose a question-
naire, which was validated in the language 
used by the patient. Unfortunately, some of 
the less common tests have not been trans-
lated into Polish and appropriate validation 
studies in Polish are lacking.
7. The target group. Before making a final cho-
ice, which questionnaire will be used in as-
sessment of asthma control, it is necessary to 
check whether it is intended for the patient. 
This applies especially to children and adole-
scents. Most of the discussed tools are meant 
for adults. Only part of the tests have a ver-
sion for patients under 18 years of age. Selec-
tion of tools for children under 4 years of age is 
problematic. In fact, only TRACK questionnaire 
is designed for such patients. Another aspect 
is proper communication between doctor and 
patient. It is important to make sure that the 
patient understands the questionnaire, as this 
will affect the answers given by him and can 
disrupt the test result. The problem of poor 
clinician-patient communication and its impact 
on asthma control is perceived in multiethnic 
countries, such as the United States [29].
8. Availability of the questionnaire and copy-
rights. It should be noted that most of the 
questionnaires are copyrighted and access 
to them can involve the need to pay fees or 
obtain permission to use them. In Table 3. we 
present internet addresses of official websi-
tes of some of the questionnaires or links to 
literature presenting the questionnaires.
The role of the questionnaires as the easy-
to-use tools to reliably assess asthma control is 
growing steadily. Their utilization is recommend-
ed in the latest GINA and NAEPP guidelines and 
they are also widely used in research studies. 
Also several questionnaires exist, that take into 
account not only the clinical parameters, but also 
laboratory measurements, such as nitric oxide 
in exhaled air or induced sputum. The results 
of studies determining the ability of some of the 
questionnaires to predict asthma exacerbations 
in the future are encouraging. Unfortunately, in 
Table 3.  Internet addresses or literature presenting the 
questionnaires or allowing to obtain them
Tabela 3.  Adresy internetowe lub pozycje piśmiennictwa, 
które pozwalają na zapoznanie się z kwestiona-
riuszami lub ich uzyskanie
GINA http://www.ginasthma.org/docu-
ments/4
Polish translation of pocket version:
http://www.ginasthma.org/docu-
ments/1/documents_variants/54
NAEPP EPR3 http://www.nhlbi.nih.gov/health-pro/
guidelines/current/asthma-guidelines/
full-report
ACT and cACT http://www.asthmacontroltest.com/
ACQ http://www.qoltech.co.uk/acq.html
ATAQ Ref. [20]
ACCI Ref. [21]
30-second Astma Test  Ref. [22]
RCP3Q Ref. [23]
TRACK Ref. [24]
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Poland the availability of translated and validat-
ed versions of questionnaires is low. Conducting 
appropriate validation studies would allow their 
wider use in clinical practice and thus improve 
asthma outcomes in our country.
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